Browsing Category: "Stock Research"
I just received a great comment regarding my recent article on valuing Microsoft. The reader noticed that I only used $9 billion in net cash to determine the intrinsic value of Microsoft shares. However, that $9 billion in net cash only included cash and equivalents. It did not include short-term investments, and Microsoft has a significant amount of [...]
As Microsoft’s stock hit a multi-year high of $31.45 today, I decided it was time to revisit my analysis of this stock. I first bought stock in Microsoft (MSFT) on October 10, 2005 and then I bought it again on May 1, 2006 when it once again dropped below $24.50.
I originally determined that MSFT had an intrinsic value of at [...]
Sally Beauty Holdings (SBH) delivered some bad news last night. The company announced that its Sally Beauty Group LLC (BSG) subsidiary will no longer have exclusive rights to distribute products of the L’Oreal Professional Products Division through its distributor sales consultants or in its stores. BSG’s Armstrong McCall division will not retain the rights to distribute [...]
Earlier this week, I detailed why I think Pfizer (PFE) has a wide moat. Today, I’m going to discuss what I believe Pfizer’s stock is actual worth. Determining a stock’s intrinsic value is critical in determining whether there is a significant margin of safety in investing in that stock.
Pfizer (PFE) is a world class pharmaceutical company that develops and manufactures leading prescription medicines. This $181 billion dollar company has many competitive advantages that give it a wide moat, which shields it from the pressures of profit eroding competition.
According to an AP story, Realogy (H) will reaffirm its guidance at a meeting this week with security analysts and investors. Realogy had previously announced that it expects full-year earnings to come in at between $250 million and $340 million on revenues of between $6.4 billion and $6.7 billion.
Given the declining real estate market, it will be interesting [...]
Back to my list of potential wide moat stocks, this week I’m going to start by looking at Coldwater Creek Inc. (CWTR). Coldwater Creek is a women’s fashion retailer. The company operates both retail stores and direct sales through their catalog and website. I am no expert on women’s fashion, so I decided to seek some [...]
Western Union (WU) has been added to the Fat Pitch Financial Portfolio. This paper port, which is similar to my actual holdings, is tracked at Marketocracy. I added 2,290 shares of Western Union this morning for an average price of $21.86.
There is nothing too complicated about my decision to purchase a stake in Western Union. I have been tracking [...]
Continuing on review of potential wide moat companies, today I’m going to take a look at Coventry Health Care Inc. (CVH). Coventry Health Care is a Bethesda, Maryland based managed healthcare company that has been in operation since 1986. The company’s services include:
Health maintenance organization (”HMO”)
Preferred provider organizations (”PPO”)
Point of service products (”POS”)
Medicare advantage
Medicare prescription [...]
Continuing my review of potential wide moat companies from a screen I ran last month, today I’m going to look at CRA International Inc. (CRAI). CRA International use to go by the name of Charles River Associates until May of 2005. CRA International is an economic, financial, and business consulting firm. They are highly involved in supporting [...]
